Corporate Bond Fund – Featured
January 11, 2022
The Latest
Fixed Income – March 2024
Highlights Large positive moves came from some deeply discounted bonds including Esperion’s 2025 notes, Lucid Group’s 2026 convertible bonds, and 2028 bonds of Emergent BioSolutions. Convertible bonds in Equinox Gold (2029) and OPKO Health (2029) provided further gains. The wide valuation divergence between certain pockets in the credit markets and the tight spreads in the high-yield bond index highlight the potential benefits of an active investing approach. The Pender Corporate Bond Fund returned 2.8% in March[1], as the Fund benefited from numerous specific catalysts that drove very strong performance. Download the PDF. Some of the Fund’s deeply discounted bonds made…
